In the analysis of circulating DNA from patients with advanced hepatocellular carcinoma, CYP2B6, BAX, and HNF1A genes showed the highest mutation frequency and a significant association with the clinicopathological characteristics of HCC, which suggested potential roles as driver genes in a specific clinical setting [51]. This evidence concerns the gene CYP2B6 and hepatocellular carcinoma.